Navigation Links
IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial

ent views of future events including statements regarding the phase II UVIDEM study and the potential for UVIDEM as a treatment for melanoma, and review of the submissions for marketing approval of JUNOVAN by the FDA and the EMEA. Actual results may differ materially from the forward-looking statements due to a number of important factors, including, but not limited to, the timing of the FDA's and EMEA's review of the submissions for marketing approval, the ability of the Company to respond to questions raised by the FDA and EMEA in a satisfactory manner, the time needed to respond to any issues raised by the FDA and EMEA with regard to regulatory submissions for JUNOVAN, although the FDA is not bound by the decision of any advisory panel, the possible negative impact that the opinion of the FDA's Oncologic Drug Advisory Committee that the results of the Company's Phase III trial do not provide substantial evidence of effectiveness of JUNOVAN in the treatment of patients with non-metastatic, resectable osteosarcoma receiving combination chemotherapy would have upon the determination by the FDA whether to approve the marketing application for JUNOVAN, which would have a material and adverse affect on IDM's business, the possibility that regulatory authorities may not consider preclinical and early clinical development work conducted by Ciba- Geigy and efficacy data from the Phase III trial conducted by Children's Oncology Group as adequate for their assessment of JUNOVAN, which may cause delays in review, may result in the regulatory authorities requiring the Company to conduct additional clinical trials, or may result in a determination by the regulatory authorities that the data does not support marketing approval, whether regulatory authorities will approve JUNOVAN within the time frame expected by the Company or at all, and whether the Company will be able to manufacture JUNOVAN even if it is approved by regulatory authorities. Other risks affecting the Company a
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Sygnis Pharma AG announces date for presentation of clinical results
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
Post Your Comments:
(Date:8/20/2014)... , Aug. 20, 2014   Ventana ... Roche  Group, today announced that its VENTANA System ... marked in the European Union for routine pathology, ... system, consisting of VENTANA Virtuoso software coupled with ... iScan HT slide scanner, provides automated digital slide ...
(Date:8/20/2014)... ARBOR, Mich. and PHOENIX ... non-profit corporation established to bring cutting-edge next-generation sequencing ... to cancer patients, today announced a collaboration with ... capabilities to characterize patient tissue samples from clinical ... sensitive or resistant to TESARO,s TSR-011.  This may lead ...
(Date:8/20/2014)... NEW YORK , Aug. 20, 2014 ... available in its catalogue: Global Feminine Hygiene ... This report analyzes the worldwide markets for Feminine ... Segments: Sanitary Pads/Towels, Tampons, Panty liners, and Others. The ... Canada , Japan , ...
Breaking Medicine Technology:Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 2Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 3Paradigm Announces Molecular Profiling Collaboration with TESARO, Inc. 2Global Feminine Hygiene Products Industry 2Global Feminine Hygiene Products Industry 3Global Feminine Hygiene Products Industry 4Global Feminine Hygiene Products Industry 5Global Feminine Hygiene Products Industry 6Global Feminine Hygiene Products Industry 7Global Feminine Hygiene Products Industry 8Global Feminine Hygiene Products Industry 9Global Feminine Hygiene Products Industry 10Global Feminine Hygiene Products Industry 11Global Feminine Hygiene Products Industry 12Global Feminine Hygiene Products Industry 13Global Feminine Hygiene Products Industry 14Global Feminine Hygiene Products Industry 15Global Feminine Hygiene Products Industry 16Global Feminine Hygiene Products Industry 17Global Feminine Hygiene Products Industry 18Global Feminine Hygiene Products Industry 19Global Feminine Hygiene Products Industry 20Global Feminine Hygiene Products Industry 21Global Feminine Hygiene Products Industry 22Global Feminine Hygiene Products Industry 23Global Feminine Hygiene Products Industry 24Global Feminine Hygiene Products Industry 25Global Feminine Hygiene Products Industry 26
... Ltd. (Sun) (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, ... Israel has unanimously dismissed the appeal by Taro Pharmaceutical ... of the previous ruling by the Tel-Aviv District Court ... do not apply to the Tender Offer by Sun,s ...
... Havel,s Incorporated, the Cincinnati-based market leader in echogenic ... echogenic ultrasound needle which could help reduce radiation ... echogenic needles using their new, innovative Micro Laser ... to reflect sound waves back to the transducer ...
Cached Medicine Technology:Supreme Court of Israel Rules in Favor of Sun Pharma 2Supreme Court of Israel Rules in Favor of Sun Pharma 3Havel's Incorporated Helping to Reduce Radiation Exposure with New EchoTuohy™ Ultrasound Needle 2
(Date:8/20/2014)... August 20, 2014 The ... (IBCCES) , an organization recognizing professionals dedicated to ... has announced that with a certificate in ... people on the Autism Spectrum have a way ... quality care. This, in turn, say IBCCES representatives, ...
(Date:8/20/2014)... 2014 Today, Zane Benefits, the ... of a new eBook, Affordable Care Act 101. ... owners feel uncertain about how the ACA impacts ... bottom line. , The new eBook outlines key ... navigate their upcoming health insurance decisions. , Read ...
(Date:8/20/2014)... August 20, 2014 A new trend ... a medical exam before issuing an approximate quote for ... company is now helping the public to obtain life ... system at http://quotespros.com/life-insurance.html . , The coverage ... more regulations have appeared in many U.S. states. Some ...
(Date:8/20/2014)... FL (PRWEB) August 20, 2014 Locating rates ... users of the Quotes Pros website. A new source of ... price and review rates good for all 50 states at ... configured is one of the new methods available for the ... insurer packages that are supplied. The instant quotations that are ...
(Date:8/20/2014)... New York, NY (PRWEB) August 20, 2014 ... Open Tennis Championship tickets in NYC. In just a ... USTA Billie Jean King Tennis Center. The event was originally founded ... the 2013 event, Rafael Nadal was forced to withdrawal from the ... of the 2014 women’s tournament and will return to New York ...
Breaking Medicine News(10 mins):Health News:National Autism Certificate Credentialing Board IBCCES Increases Job Placement Opportunities for Those Dedicated to Working Within the Autism Spectrum 2Health News:National Autism Certificate Credentialing Board IBCCES Increases Job Placement Opportunities for Those Dedicated to Working Within the Autism Spectrum 3Health News:Life Insurance Quotes Without Medical Exams Now Displayed to Adults at Insurance Website 2Health News:Term Life Insurance Price Database Now Helps Quote Prices for Adults in 50 States Online 2Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 2Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 3Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 4Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 5
... studies published in the May issue of the journal ... the staggering economic impact of toxic chemicals and air pollutants ... of new chemicals and also those already on the market. ... and Pediatrics at Mount Sinai School of Medicine, analyzed the ...
... Salamon HealthDay Reporter , WEDNESDAY, May 4 (HealthDay ... concussion while playing sports should immediately pull players off the ... -- to avoid a potentially permanent brain injury, according to ... on youth sports injury prevention held by Safe Kids USA, ...
... and HIV (K-RITH) has awarded a total of 1.7 ... and students to help build new tuberculosis and HIV ... first Collaborative Grants awarded by K-RITH, which was founded ... KwaZulu-Natal (UKZN) and the Howard Hughes Medical Institute (HHMI). ...
... who received therapy for cancer during childhood have ... later in life, according to a new study ... the American Gastroenterological Association (AGA) Institute. Compared with ... of late-onset complications of the upper GI tract, ...
... , WEDNESDAY, May 4 (HealthDay News) -- Adults ... but simply asking teens about their wishes and hopes revealed ... adolescents, aged 11 to 18, who completed a health screening ... wishes, what would they be?" The researchers found that ...
... address the often-overlooked costs associated with atrial fibrillation (AFib), ... study evaluates these costs and updates a growing body ... are complex and may not yet be fully understood. ... ATHENA trial, a placebo-controlled, double-blind, parallel arm trial to ...
Cached Medicine News:Health News:Estimated costs of environmental disease in children at $76.6 billion per year 2Health News:Estimated costs of environmental disease in children at $76.6 billion per year 3Health News:Football Legend Steve Young Urges Kids, Parents to Play It Safe 2Health News:Football Legend Steve Young Urges Kids, Parents to Play It Safe 3Health News:K-RITH awards grants to foster teamwork among South African TB/HIV scientists 2Health News:Childhood cancer survivors are at increased risk for ongoing post-therapy GI complications 2Health News:Simple Question Sheds Light on Teens' Hopes, Dreams 2Health News:Data evaluates rehospitalization and cost burden of AFib/atrial flutter 2
... the world's first directly illuminated, hand-held ... tradition of bringing superior ophthalmic technology ... keeping with that tradition, Welch Allyn ... Ophthalmoscope. With its newly designed precision ...
... The TOPCON 3D+ ALE-3700/3700PC/3700CF patternless processing system ... frame, quickly, accurately and with the convenience ... the 3D+ FR-20 Frame Reader, advanced processing ... is available with a polycarbonate feature (ALE-3700 ...
Inquire...
... Model II, is very simple to use ... obtained because it is only necessary to ... with internal reading scales then indicating the ... Since displacements between the centers of spectacle ...
Medicine Products: